title: Time delays in provision of thrombolytic treatment in six district hospitals. Joint Audit Committee of the British Cardiac Society and a Cardiology Committee of Royal College of Physicians of London.
abstract: OBJECTIVE
  To measure the delays between onset of symptoms and admission to hospital and provision of thrombolysis in patients with possible acute myocardial infarction.
  
  
  METHODS
  Observational study of patients admitted with suspected myocardial infarction during six months.
  
  
  METHODS
  Six district general hospitals in Britain.
  
  
  METHODS
  1934 patients admitted with suspected myocardial infarction.
  
  
  METHODS
  Route of admission to hospital and time to admission and thrombolysis.
  
  
  RESULTS
  Patients who made emergency calls did so sooner after onset of symptoms than those who called their doctor (median time 40 (95% confidence interval 30 to 52) minutes v 70 (60 to 90) minutes). General practitioners took a median of 20 (20 to 25) minutes to visit patients, rising to 30 (20 to 30) minutes during 0800-1200. The median time from call to arrival in hospital was 41 (38 to 47) minutes for patients who called an ambulance from home and 90 (90 to 94) minutes for those who contacted their doctor. The median time from arrival at hospital to thrombolysis was 80 (75 to 85) minutes for patients who were treated in the cardiac care unit and 31 (25 to 35) minutes for those treated in the accident and emergency department.
  
  
  CONCLUSIONS
  The time from onset of symptoms to thrombolysis could be reduced substantially by more effective use of emergency services and faster provision of thrombolysis in accident and emergency departments.
authors.affiliation: Department of Medicine, Northampton General Hospital.
authors.forename: J S
authors.initials: JS
authors.lastname: Birkhead
mesh_terms: D004334:Drug Administration Schedule; D004632:Emergency Medical Services / Q000592:standards*; D004636:Emergency Service, Hospital / Q000592:standards*; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006767:Hospitals, District / Q000592:standards; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D010343:Patient Admission; D015912:Thrombolytic Therapy; D013996:Time and Motion Studies; D014187:Transportation of Patients; D006113:United Kingdom
chemical_list: D005343:Fibrinolytic Agents